Proceedings of the National Academy of Sciences · 2008 · 553 citations · 41 references
Life SciencesBiochemistryNeuroscienceMolecular NeuroscienceNeurodegenerationStructural BiologyAmyloid FormationNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseProtein AggregationProtein StructureAggregation IntermediatesAlpha-synuclein AggregationAlpha-synuclein MisfoldingAmyloid Fibril StructureAmyloid FibrilsAmyloid StructureAmyloidogenic IntermediatesHydrogen-deuterium Exchange Spectroscopy
The aggregation of proteins into amyloid fibrils is associated with several neurodegenerative diseases. In Parkinson's disease it is believed that the aggregation of alpha-synuclein (alpha-syn) from monomers by intermediates into amyloid fibrils is the toxic disease-causative mechanism. Here, we studied the structure of alpha-syn in its amyloid state by using various biophysical approaches. Quenched hydrogen/deuterium exchange NMR spectroscopy identified five beta-strands within the fibril core comprising residues 35-96 and solid-state NMR data from amyloid fibrils comprising the fibril core residues 30-110 confirmed the presence of beta-sheet secondary structure. The data suggest that beta1-strand interacts with beta2, beta2 with beta3, beta3 with beta4, and beta4 with beta5. High-resolution cryoelectron microscopy revealed the protofilament boundaries of approximately 2 x 3.5 nm. Based on the combination of these data and published structural studies, a fold of alpha-syn in the fibrils is proposed and discussed.
41
Structure of the cross-β spine of amyloid-like fibrils
Rebecca A. Nelson, M.R. Sawaya, Melinda Balbirnie et al. · Nature · 2005 · 2.2K citations · Full text
A Drosophila model of Parkinson's disease
Mel Β. Feany, Welcome Bender · Nature · 2000 · 2.1K citations
α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models
Antony A. Cooper, Aaron D. Gitler, Anil G. Cashikar et al. · Science · 2006 · 1.4K citations · Full text